United States insulin delivery devices market is expected to grow at a significant rate during the forecast period. Increasing prevalence of diabetes due to consumption of unhealthy eating habits comprising of junk food and high sugar containing edible food items and beverages leading to obesity is the major driver for the forecast period. Adoption of sedentary lifestyle due to long working hours which leaves less time left for physical activities is giving rise to a number of diseases. Changing lifestyle and adoption of smoking and drinking is affecting the health condition of patients adversely. Diabetes can be cured by permanent treatment solution yet, but it can be controlled by taking insulin at required levels on right time. Patients suffering from type-1 diabetes require the dose of insulin to maintain the sugar level in the body as patients are not able to produce insulin on their own and require the help of insulin devices. Strong economic position and well-developed healthcare infrastructure is influencing the growth of the market. Favorable reimbursement policies and support of the government to promote the healthcare industry and increase the affordability of availing healthcare services.

United States insulin delivery devices market is segmented into product type, distribution channel, end user, regional distribution, and company. Based on end user, market can be divided into hospitals & clinics, homecare, and others. The homecare segment is expected to witness fastest incremental growth for the forecast period, 2022-2026. Rise in consumer awareness regarding the adverse effects of diabetes along with presence of disposable income is accelerating the demand for insulin delivery devices. The use of insulin device at home saves other expenses like visiting costs, doctor’s fees, along with the time involved to visit the hospital facility.

The major players operating in the United States insulin delivery devices market are Medtronic USA, Inc., Roche Diagnostics Corporation, Becton, Dickinson and Company, Novo Nordisk Inc., Sanofi-Aventis U.S. LLC, Eli Lilly & Company, Abbott Laboratories, Inc., B. Braun Medical Inc., Tandem Diabetes Care, Inc., Insulet Corporation, among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of United States insulin delivery devices market from 2016 to 2019.
  • To estimate and forecast the market size of United States insulin delivery devices market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast United States insulin delivery devices market based on product type, distribution channel, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States insulin delivery devices.
  • To identify drivers and challenges for United States insulin delivery devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States insulin delivery devices market.
  • To identify and analyze the profile of leading players operating in United States insulin delivery devices market.
  • To identify key sustainable strategies adopted by market players in United States insulin delivery devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States insulin delivery devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Insulin delivery devices manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to insulin delivery devices market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States insulin delivery devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Insulin Delivery Devices Market, By Product Type:

    • Pens
    • Pumps
    • Pen Needles
    • Others
  • United States Insulin Delivery Devices Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online
    • Others
  • United States Insulin Delivery Devices Market, By End User:
    • Hospitals & Clinics
    • Homecare
    • Others
  • United States Insulin Delivery Devices Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States insulin delivery devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States insulin delivery devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Insulin Delivery Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Insulin Delivery Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Pens, Pumps, Pen Needles, Others)

6.2.2.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others)

6.2.3.     By End User (Hospitals & Clinics, Homecare, Others)

6.2.4.     By Region

6.2.5.     By Company (FY2021)

6.3.  Product Market Map

7.    United States Insulin Delivery Pens Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Disposable v/s Reusable)

7.2.2.     By Distribution Channel

7.2.3.     By End User

8.    United States Insulin Delivery Pumps Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (External/Tethered Pumps v/s Patch Pumps)

8.2.2.     By Distribution Channel

8.2.3.     By End User

9.    United States Insulin Delivery Pen Needles Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Standard Pen Needles v/s Safety Pen Needles)

9.2.2.     By Distribution Channel

9.2.3.     By End User

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

12.  Policy & Regulatory Landscape

13.  Import-Export Analysis

14.  United States Economic Profile

15.  Competitive Landscape

15.1.              Company Profiles

15.1.1.  Medtronic USA, Inc.

15.1.2.  Roche Diagnostics Corporation

15.1.3.  Becton, Dickinson and Company

15.1.4.  Novo Nordisk Inc.

15.1.5.  Sanofi-Aventis U.S. LLC

15.1.6.  Eli Lilly & Company

15.1.7.  Abbott Laboratories, Inc.

15.1.8.  B. Braun Medical Inc.

15.1.9.  Tandem Diabetes Care, Inc.

15.1.10.                Insulet Corporation

16.  Strategic Recommendations

17.  About us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]